Emanera 40mg Krka Treatment Treatment of Gastroesophageal reflux (4 blisters x 7 tablets)
Dosage form Box of 4 blisters x 7 tablets
Specifications Esomeprazol
Ingredient
| Composition information | Content |
| Esomeprazol | 40mg |
Uses
indications
Emanera 40mg drug indicated in the following cases:
adolescents over 12 years old
Gastroesophageal reflux disease (GERD):
Adults
Gastroesophageal reflux disease (GERD):
pharmacokinetics
No data ,.
Before taking Emanera 40mg Krka Treatment Treatment of Gastroesophageal reflux (4 blisters x 7 tablets)
How to use
EMANERA 40mg drug used oral. Take medicine at any time of the day.
Can be taken before or after eating.
Swallow the tablet with water, do not chew or crush before drinking.
Dosage
Adults and children over 12 years old
Gastroesophageal reflux disease:
People with kidney function damage: No need to adjust the dose in patients with renal function damage. Due to less experience in using drugs in patients.
People who damage liver function: No need to reduce the dose in people with liver function damage to a mild to medium level. In patients with severe liver failure, maximum overdose of 20mg Esomeprazol.
Elderly: No need to adjust the dose in the elderly.
Children under 12 years of age: There is no research data when using Esomeprazol for children under 12 years old.
Note: The above dose is for reference only. Specific dosage depends on the condition and level of progression of the disease. For a suitable dose, you need to consult a doctor or medical specialist.What to do when using overdose?
What to do when you forget 1 dose? However, if the time to relax with the next dose is too short, skip the dose and continue the calendar of the drug. Do not use double dose to compensate for missed dose.
Side Effects
Unwanted effects (ADR) when using Emanera 40mg that you may encounter:
Common
Rare:
Warnings
Before using the drug you need to read the instructions carefully and refer to the information below.
contraindicated
EMANERA 40mg drug contraindicated in the following cases:
Be cautious when using
when there is any alarm symptom (such as significant weight loss, recurrent vomiting, difficulty swallowing, vomiting blood or black stools) and suspicion or stomach ulcers should eliminate malignant diseases because Esomeprazol treatment can reduce symptoms and delay diagnostic.
Patients with long -term treatment (especially in people who treat more than 1 year) should be monitored regularly.
Patients treated according to the regime when necessary should contact the doctor if there are symptoms that change in characteristics. When prescribing Esomeprazol according to the treatment regime when necessary, it is advisable to consider the interaction associated with other drugs due to the change in the plasma Esomeprazol level.
Patients with rare genetic problems such as fructose intolerance, malventia-galucose-galactose loss of sucrase-isomaltase lack of esomeprazol should not be used.
Proton pump inhibitors may increase the risk of gastrointestinal infections compared to Salmonella and Campylobacter.
It is not recommended to simultaneously use Esomeprazol with Atazanavir. If the combination of Atazanavir with proton pump inhibitors is inevitable, closely monitoring.
Esomeprazol can reduce vitamin B12 absorption. Therefore, it is necessary to consider when using drugs in people with reduced vitamin B12 reserves or risk factors for reducing vitamin B12 absorption when long -term treatment.
Do not encourage simultaneous use of esomeprazol and clopidogrel.
Patients with osteoporosis should be taken care of under the current clinical instructions and should be added with an appropriate amount of vitamin D and calcium.
Drug interaction
Esomeprazol's impact on pharmacokinetics of other drugs:
For pH -dependent absorption drugs: It is not recommended to use Esomeprazol simultaneously with Atazanavir and contraindicated using Esomeprazol simultaneously with Nelfinavir.
Metabolic drugs simultaneously with nelfinavir.
CYP2C19 metabolic drugs:
Effect of other drugs on Esomeprazole's pharmacokinetics:
Storage
Leave a cool place, avoid light, temperature below 30⁰C.
Other drugs
- ALLEGRON TABLETS 10MG
- ETORICOXIB 120MG TABLETS
- Eucreas
- Fosavance
- HARTMANNS SOLUTION
- Pantoloc Control
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions